Zobrazeno 1 - 10
of 873
pro vyhledávání: '"Shifrin, N."'
Autor:
Araujo HA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pechuan-Jorge X; Revolution Medicines, Redwood City, California., Zhou T; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Do MT; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hu X; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rojas Alvarez FR; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Salvatierra ME; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ibarguen HP; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Raghulan R; Revolution Medicines, Redwood City, California., Shah H; Revolution Medicines, Redwood City, California., Moreno Ayala MA; Revolution Medicines, Redwood City, California., Chen K; Revolution Medicines, Redwood City, California., Tovbis Shifrin N; Revolution Medicines, Redwood City, California., Wu S; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Solis Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Negrao MV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hong DS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jiang J; Revolution Medicines, Redwood City, California., Singh M; Revolution Medicines, Redwood City, California., Smith JAM; Revolution Medicines, Redwood City, California., Quintana E; Revolution Medicines, Redwood City, California., Skoulidis F; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Nov 01; Vol. 14 (11), pp. 2183-2208.
Autor:
Holderfield M; Revolution Medicines, Redwood City, CA, USA., Lee BJ; Revolution Medicines, Redwood City, CA, USA., Jiang J; Revolution Medicines, Redwood City, CA, USA., Tomlinson A; Revolution Medicines, Redwood City, CA, USA., Seamon KJ; Revolution Medicines, Redwood City, CA, USA., Mira A; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy., Patrucco E; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy., Goodhart G; Department of Surgery, University of Cincinnati, Cincinnati, OH, USA., Dilly J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gindin Y; Revolution Medicines, Redwood City, CA, USA., Dinglasan N; Revolution Medicines, Redwood City, CA, USA., Wang Y; Revolution Medicines, Redwood City, CA, USA., Lai LP; Revolution Medicines, Redwood City, CA, USA., Cai S; Revolution Medicines, Redwood City, CA, USA., Jiang L; Revolution Medicines, Redwood City, CA, USA., Nasholm N; Revolution Medicines, Redwood City, CA, USA., Shifrin N; Revolution Medicines, Redwood City, CA, USA., Blaj C; Revolution Medicines, Redwood City, CA, USA., Shah H; Revolution Medicines, Redwood City, CA, USA., Evans JW; Revolution Medicines, Redwood City, CA, USA., Montazer N; Revolution Medicines, Redwood City, CA, USA., Lai O; Revolution Medicines, Redwood City, CA, USA., Shi J; Revolution Medicines, Redwood City, CA, USA., Ahler E; Revolution Medicines, Redwood City, CA, USA., Quintana E; Revolution Medicines, Redwood City, CA, USA., Chang S; Revolution Medicines, Redwood City, CA, USA., Salvador A; Revolution Medicines, Redwood City, CA, USA., Marquez A; Revolution Medicines, Redwood City, CA, USA., Cregg J; Revolution Medicines, Redwood City, CA, USA., Liu Y; Revolution Medicines, Redwood City, CA, USA., Milin A; Revolution Medicines, Redwood City, CA, USA., Chen A; Revolution Medicines, Redwood City, CA, USA., Ziv TB; Revolution Medicines, Redwood City, CA, USA., Parsons D; Revolution Medicines, Redwood City, CA, USA., Knox JE; Revolution Medicines, Redwood City, CA, USA., Klomp JE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Roth J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rees M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ronan M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cuevas-Navarro A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hu F; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lito P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Santamaria D; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Waters AM; Department of Surgery, University of Cincinnati, Cincinnati, OH, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA., Der CJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy., Wang Z; Revolution Medicines, Redwood City, CA, USA., Gill AL; Revolution Medicines, Redwood City, CA, USA., Koltun ES; Revolution Medicines, Redwood City, CA, USA., Smith JAM; Revolution Medicines, Redwood City, CA, USA. jan@revmed.com., Wildes D; Revolution Medicines, Redwood City, CA, USA. pete@revmed.com., Singh M; Revolution Medicines, Redwood City, CA, USA. msingh@revmed.com.
Publikováno v:
Nature [Nature] 2024 May; Vol. 629 (8013), pp. 919-926. Date of Electronic Publication: 2024 Apr 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Blaj, C., Menard, M., Tobvis Shifrin, N., Chen, K., Chow, C., Courtney, H., Kumamoto, A., Velilla, T., Evans, J.W., Lawrence, L., Vonmelchert, B., Kwok-Parkhill, A., Singh, M., Smith, J.A., Quintana, E.
Publikováno v:
In European Journal of Cancer October 2022 174 Supplement 1:S59-S59
Autor:
Raghavan S; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States.; Department of Microbiology and Immunology, Institute for Biomedicine, University of Gothenburg, Gothenburg, Sweden., Tovbis-Shifrin N; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Kochel C; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Sawant A; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Mello M; Centre d'Immunophénomique - CIPHE (PHENOMIN), Aix Marseille Université (UMS3367), National Institute of Health and Medical Research (INSERM) (US012), The French National Centre for Scientific Research (CNRS) (UMS3367), Marseille, France., Sathe M; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Blumenschein W; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Muise ES; Merck & Co., Inc., Boston, MA, United States., Chackerian A; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States., Pinheiro EM; Merck & Co., Inc., Boston, MA, United States., Rosahl TW; Merck & Co., Inc., Kenilworth, NJ, United States., Luche H; Centre d'Immunophénomique - CIPHE (PHENOMIN), Aix Marseille Université (UMS3367), National Institute of Health and Medical Research (INSERM) (US012), The French National Centre for Scientific Research (CNRS) (UMS3367), Marseille, France., de Waal Malefyt R; Department of Immunology, Merck & Co., Inc., Palo Alto, CA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Nov 29; Vol. 12, pp. 752348. Date of Electronic Publication: 2021 Nov 29 (Print Publication: 2021).
Autor:
Hammoud, Mohamad K.1,2 (AUTHOR), Meena, Celina3 (AUTHOR), Dietze, Raimund1 (AUTHOR), Hoffmann, Nathalie3 (AUTHOR), Szymanski, Witold4,5 (AUTHOR), Finkernagel, Florian1,3,6 (AUTHOR), Nist, Andrea6 (AUTHOR), Stiewe, Thorsten6 (AUTHOR), Graumann, Johannes4,5 (AUTHOR), von Strandmann, Elke Pogge3,7 (AUTHOR) poggevon@staff.uni-marburg.de, Müller, Rolf1,7 (AUTHOR) rolf.mueller@uni-marburg.de
Publikováno v:
Cell Communication & Signaling. 11/19/2024, Vol. 22 Issue 1, p1-23. 23p.
Autor:
Keightley, Samuel1 (AUTHOR) samuel.1.keightley@kcl.ac.uk, Pollmann, Ayla1 (AUTHOR) ayla.pollmann@kcl.ac.uk, Gardner, Benjamin2 (AUTHOR) benjamin.gardner@surrey.ac.uk, Duncan, Myanna1 (AUTHOR) myanna.duncan@kcl.ac.uk
Publikováno v:
Behavioral Sciences (2076-328X). Nov2024, Vol. 14 Issue 11, p1039. 17p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Annals of Oncology October 2018 29 Supplement 8
Autor:
Akgül, Rıza1 rizaakgul@gmail.com
Publikováno v:
Ciência Rural. 2024, Vol. 54 Issue 9, p1-10. 10p.